Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
Single-gene systems-level effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 April.
Single-gene systems-level effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 April.
‘The Brain, In Theory,’ an excerpt
In his new book, Brette pushes back against theories that describe the brain as a “biological computer.” In this excerpt from Chapter 4, he challenges equating brain evolution with programming, and the universality of neural network models.
‘The Brain, In Theory,’ an excerpt
In his new book, Brette pushes back against theories that describe the brain as a “biological computer.” In this excerpt from Chapter 4, he challenges equating brain evolution with programming, and the universality of neural network models.
Computational neuroscientist Keith Hengen explains his work through illustrations
The images help him communicate the “big-picture ideas” behind the mathematical principles of neuronal networks.
Computational neuroscientist Keith Hengen explains his work through illustrations
The images help him communicate the “big-picture ideas” behind the mathematical principles of neuronal networks.